×
About 20,563 results

ALLMedicine™ Vasculitis Center

Research & Reviews  6,941 results

Towards better indications for kidney biopsy in adult IgA vasculitis: a clinical-labora...
https://doi.org/10.1007/s40620-022-01389-8
Journal of Nephrology; Maisons V, Halimi JM et. al.

Aug 14th, 2022 - Indications for kidney biopsy in adult IgA vasculitis (IgAV) remain debated and there are very few studies on this subject. The aim of this study was to establish a correlation between renal histological and clinical-laboratory data. A retrospecti...

Comparative analysis of complement C3 and C4 serum levels for outcome prediction in ANC...
https://doi.org/10.1007/s40620-022-01414-w
Journal of Nephrology; Tampe D, Baier E et. al.

Aug 14th, 2022 - The activation of the complement system contributes essentially to the pathogenesis of anti-neutrophil cytoplasmic antibody (ANCA)-associated renal vasculitis. We here aimed to directly compare levels of C3 and C4 for outcome prediction in ANCA-as...

Locations and Predictive Factors of Hypertrophic Pachymeningitis in Otitis Media With A...
https://doi.org/10.1097/MAO.0000000000003610
Otology & Neurotology : Official Publication of the Ameri... Morita Y, Kitazawa M et. al.

Aug 13th, 2022 - To determine the locations and predictive factors of hypertrophic pachymeningitis (HP), a serious central complication of otitis media with antineutrophil cytoplasmic antigen-associated vasculitis (OMAAV). Retrospective study. University hospital....

A Study to Evaluate Guselkumab for the Treatment of Participants With New-onset or Relapsing Giant Cell Arteritis
https://clinicaltrials.gov/ct2/show/NCT04633447

Aug 12th, 2022 - Giant cell arteritis (GCA) is a non-necrotizing granulomatous systemic vasculitis of unknown etiology affecting medium-sized and large arteries usually accompanied or preceded by systemic inflammation. Guselkumab is a monoclonal antibody (mAb) tha...

The Pathogenesis and Natural History of Sjogren s Syndrome
https://clinicaltrials.gov/ct2/show/NCT01425892

Aug 12th, 2022 - BACKGROUND Sj(SqrRoot)(Delta)gren s syndrome (SS) is an autoimmune disease characterized by chronic inflammation involving the exocrine glands. Salivary and lacrimal glands are predominantly affected leading to dry mouth and dry eyes but other exo...

see more →

Guidelines  22 results

2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki Disease
https://www.rheumatology.org/Portals/0/Files/Guideline-Management-Kawasaki-Disease.pdf
American College of Rheumatology; Gorelik M, .

Mar 8th, 2022 - Kawasaki disease (KD) is a medium vessel vasculitis as presented in the Chapel Hill Consensus Conference nomenclature system (1). It is 1 of 2 primary common vasculitis syndromes that predominantly affect children (the other being IgA vasculitis...

Plasma exchange and glucocorticoid dosing for patients with ANCA-associated vasculitis:...
https://doi.org/10.1136/bmj-2021-064597
BMJ (Clinical Research Ed.); Zeng L, Walsh M et. al.

Feb 27th, 2022 - What is the role of plasma exchange and what is the optimal dose of glucocorticoids in the first 6 months of therapy of patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV)? This guideline was triggered by the publi...

2022 American College of Rheumatology/European Alliance of Associations for Rheumatolog...
https://doi.org/10.1002/art.41982
Arthritis & Rheumatology (Hoboken, N.J.); Grayson PC, Ponte C et. al.

Feb 3rd, 2022 - To develop and validate revised classification criteria for eosinophilic granulomatosis with polyangiitis (EGPA). Patients with vasculitis or comparator diseases were recruited into an international cohort. The study proceeded in 5 phases: 1) iden...

2022 American College of Rheumatology/European Alliance of Associations for Rheumatolog...
https://doi.org/10.1002/art.41986
Arthritis & Rheumatology (Hoboken, N.J.); Robson JC, Grayson PC et. al.

Feb 3rd, 2022 - To develop and validate revised classification criteria for granulomatosis with polyangiitis (GPA). Patients with vasculitis or comparator diseases were recruited into an international cohort. The study proceeded in 5 phases: 1) identification of ...

2022 American College of Rheumatology/European Alliance of Associations for Rheumatolog...
https://doi.org/10.1002/art.41983
Arthritis & Rheumatology (Hoboken, N.J.); Suppiah R, Robson JC et. al.

Feb 3rd, 2022 - To develop and validate classification criteria for microscopic polyangiitis (MPA). Patients with vasculitis or comparator diseases were recruited into an international cohort. The study proceeded in 5 phases: 1) identification of candidate items ...

see more →

Drugs  193 results see all →

Clinicaltrials.gov  326 results

A Study to Evaluate Guselkumab for the Treatment of Participants With New-onset or Relapsing Giant Cell Arteritis
https://clinicaltrials.gov/ct2/show/NCT04633447

Aug 12th, 2022 - Giant cell arteritis (GCA) is a non-necrotizing granulomatous systemic vasculitis of unknown etiology affecting medium-sized and large arteries usually accompanied or preceded by systemic inflammation. Guselkumab is a monoclonal antibody (mAb) tha...

The Pathogenesis and Natural History of Sjogren s Syndrome
https://clinicaltrials.gov/ct2/show/NCT01425892

Aug 12th, 2022 - BACKGROUND Sj(SqrRoot)(Delta)gren s syndrome (SS) is an autoimmune disease characterized by chronic inflammation involving the exocrine glands. Salivary and lacrimal glands are predominantly affected leading to dry mouth and dry eyes but other exo...

Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
https://clinicaltrials.gov/ct2/show/NCT02257866

Aug 12th, 2022 - The purpose of this protocol is to study the natural history of idiopathic systemic vasculitis in children and adults. The idiopathic vasculitides are a group of rare, systemic diseases involving inflammation of arteries and other tissue with resu...

PR3-AAV Resilient Remission or PRRR
https://clinicaltrials.gov/ct2/show/NCT05376319

Aug 4th, 2022 - The purpose of this study is to evaluate the efficacy and safety of obinutuzumab for the treatment of proteinase 3 Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (PR3-AAV).

Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
https://clinicaltrials.gov/ct2/show/NCT05003986

Aug 2nd, 2022 - This is a multicenter, open-label, 112-week study of sparsentan in approximately 57 pediatric subjects aged ≥1 year to <18 years with selected proteinuric glomerular diseases, divided into 2 populations, defined as follows: Population 1: Subjects ...

see more →

News  725 results

A healthy White male presented with a rash consisting of erythematous to purpuric macules
https://www.mdedge.com/dermatology/article/256333/medical-dermatology/healthy-white-male-presented-rash-consisting
Donna Bilu Martin, MD

Jul 18th, 2022 - Vasculitis is a process in which blood vessels become inflamed and necrotic. Classic small vessel vasculitis reveals a leukocytoclastic vasculitis and most commonly presents as palpable purpura.

Pain and photophobia
https://www.mdedge.com/psoriatic-arthritis-challenge-center/article/256212/psoriatic-arthritis/pain-and-photophobia

Jul 12th, 2022 - On the basis of the patient's medical history and presentation, this is probably a case of uveitis, a common extra-articular manifestation of psoriatic disease. In fact, the presence of uveitis can help distinguish PsA from osteoarthritis.

FDA Approves Brolucizumab for Diabetic Macular Edema
https://www.medscape.com/viewarticle/975248

Jun 8th, 2022 - The US Food and Drug Administration (FDA) has approved brolucizumab (Beovu) for treatment of diabetic macular edema (DME), but included a warning about retinal vasculitis and retinal vascular occlusion. In clinical trials, patients needed fewer in...

Updated EULAR recommendations for AAV include new drugs, practices
https://www.mdedge.com/rheumatology/article/255157/lupus-connective-tissue-diseases/updated-eular-recommendations-aav
Sara Freeman

Jun 2nd, 2022 - The European Alliance of Associations for Rheumatology has updated its recommendations for the management of antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV). The 2022 revision – which was unveiled at the annual European Cong.

Sweet Syndrome With Pulmonary Involvement Preceding the Development of Myelodysplastic Syndrome
https://www.mdedge.com/dermatology/article/255144/mixed-topics/sweet-syndrome-pulmonary-involvement-preceding-development
David Y. Chen, MD, PhD, Arthur Z. Eisen, MD

Jun 2nd, 2022 - To the Editor: A 59-year-old man was referred to our clinic for a rash, fever, and night sweats following treatment for metastatic seminoma with cisplatin and etoposide. Physical examination revealed indurated erythematous papules and plaques on t.

see more →

Patient Education  18 results see all →